ALBENZA (Amedra Pharmaceuticals LLC)
Welcome to the PulseAid listing for the ALBENZA drug offered from Amedra Pharmaceuticals LLC. This Antihelminthic [EPC],Cytochrome P450 1A Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Amedra Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | albendazole |
SUBSTANCE NAME: | ALBENDAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antihelminthic [EPC],Cytochrome P450 1A Inducers [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1996-06-11 |
END MARKETING DATE: | 0000-00-00 |
ALBENZA HUMAN PRESCRIPTION DRUG Details:
Item Description | ALBENZA from Amedra Pharmaceuticals LLC |
LABELER NAME: | Amedra Pharmaceuticals LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 1996-06-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52054-550_cf83e8d6-1685-4c0a-9555-d4d19ff2bf71 |
PRODUCT NDC: | 52054-550 |
APPLICATION NUMBER: | NDA020666 |
Other ALBENDAZOLE Pharmaceutical Manufacturers / Labelers: